Individualised treatment for multidrug‐resistant tuberculosis in New South Wales, Australia
Abstract Objective: Multidrug‐resistant tuberculosis (MDR‐TB) presents a major global health challenge. In high‐income countries, treatment is individualised to optimise efficacy and reduce toxicity. We aimed to evaluate the outcomes of patients with MDR‐TB receiving individualised antibiotic therap...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Australian and New Zealand Journal of Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1111/1753-6405.13144 |